New syrup could ease wheezing in children with bronchitis
NCT ID NCT06411925
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a syrup called Atock Dry Syrup can reduce wheezing in children aged 6 months to 12 years with acute bronchitis. About 296 kids will receive either the syrup or a standard patch treatment. The main goal is to see if wheezing improves within 3 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Atock Dry Syrup (active ingredient not specified in lay terms; likely a bronchodilator or antitussive)
- What this could lead to
- If it works, this could provide a new, easy-to-take syrup option for relieving wheezing in children with acute bronchitis.
- What could go wrong
- This is a late-stage trial but compares two existing treatments, so the new syrup may not be better than the patch. Also, results may not apply to children with chronic lung conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE BRONCHITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Soonchunhyang University Seoul Hospital
RECRUITINGSeoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug raphamin aims to shorten bronchitis suffering
- New bronchitis drug shows promise in large trial
- 230,000 patient records reveal antibiotic prescribing patterns for lung infections
- Info sheets may curb unnecessary antibiotics for colds and sore throats
- New study aims to curb antibiotic overuse for coughs and colds
- Herbal remedy may speed bronchitis recovery